Company profile
Ab Initio Pharma company profile
Ab Initio Pharma operates in the biotechnology industry, focusing on pharmaceutical manufacturing. The company provides research and development services, formulation support, and GMP (Good Manufacturing Practice) product manufacturing. It is known for its involvement in clinical trials, including the production of GMP MDIs for InhaleRX's Phase 1 Clinical Trial. Ab Initio Pharma emerged as a spin-off from the University of Sydney, collaborating with the Sydney Local Health District. The company aims to offer cost-effective manufacturing solutions, particularly for small-scale projects, and serves as a training facility in the pharmaceutical sector.
Business identity
- Website
- https://ab-initio-pharma.com
- Phone number
- +61 4 0377 1606
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2019-01-01
Headquarters
- Headquarters
- Camperdown, Victoria, Australia
- Postal code
- 2050
- Country code
- AU
- Continent
- Oceania